DOCSLIB.ORG

Clopixol Tablets Are Used for the Before You Use It Acute and Long-Term Treatment of Do Not Use It After the Expiry Date Printed on the Pack

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clopixol Tablets Are Used for the Before You Use It Acute and Long-Term Treatment of Do Not Use It After the Expiry Date Printed on the Pack Clopixol (clo-PIK-sol) Clopixol Tablets 10 mg Clopixol Acuphase Injection 50 mg/mL Clopixol Depot Injection 200 mg/mL Zuclopenthixol hydrochloride (zoo-clo-PEN-thic-sol high-dro-CLOR-ride) Zuclopenthixol acetate (zoo-clo-PEN-thic-sol AS-se-tate) Zuclopenthixol decanoate (zoo-clo-PEN-thic-sol deck-can-OH-ate) Consumer Medicine Information (CMI) What is in this leaflet Clopixol Acuphase injection is used ingredients listed at the end of this for the initial treatment of acute leaflet. This leaflet contains answers to episodes of mental disorders. It is Symptoms of an allergic reaction may some common questions about also used to treat mania (a mental include shortness of breath, wheezing Clopixol. condition characterised by episodes or difficulty breathing, swelling of the of overactivity, elation or irritability) face, lips, tongue or other parts of the It does not contain all the and used in case of worsening of body, or rash, itching or hives on the information that is known about chronic mental conditions. skin. Clopixol. It does not take the place of talking to your doctor or Clopixol Depot injection is usually Do not use Clopixol if you have: pharmacist. used to prevent further episodes of ⋅ collapse due to very low blood your illness. pressure All medicines have risks and ⋅ diminished consciousness due to benefits. Your doctor has weighed Clopixol belongs to a group of any cause the risk of you using this medicine medicines called thioxanthene against the benefits he/she expects it neuroleptics. It helps to correct ⋅ brain damage will have for you. chemical imbalances in the brain, ⋅ diseases of the blood with which may cause mental illness. abnormal or reduced number of red If you have any concerns about or white blood cells or platelets using this medicine, ask your Your doctor, however, may prescribe doctor or pharmacist. it for another purpose. ⋅ phaeochromocytoma, a rare tumour of the adrenal gland which sits near Ask your doctor if you have any Keep this leaflet with the the kidney. medicine. questions about why it has been You may need to read it again. prescribed for you. Do not give Clopixol to anyone who currently has alcohol poisoning, or This medicine is only available with poisoning with medicines used to a doctor’s prescription. produce calmness or to help you Clopixol is not addictive. sleep, or medicines used to treat What Clopixol is epilepsy or strong pain. used for Do not give Clopixol to anyone who is unconscious or in a coma. Clopixol tablets are used for the Before you use it acute and long-term treatment of Do not use it after the expiry date printed on the pack. schizophrenia and other mental When you must not use it If you use it after the expiry date has illnesses with disturbances in passed, it may not work as well. The thinking, emotional reactions and Do not use Clopixol if you are expiry date refers to the last day of the behaviour. allergic to it, to any other similar month. medicines (such as thioxanthenes It is also used to treat the manic or phenothiazines), or any of the phase of manic depressive illness. A Do not use it if the packaging is torn or shows signs of tampering. manic phase is a mood of excitement, over-activity and uninhibited behaviour. 1 Before you start to use it ⋅ glaucoma, a condition in If you have not told your doctor which there is usually a build- about any of the above, tell them Tell your doctor if: up of pressure in the eye before you use Clopixol. 1. you have allergies to any ⋅ heart and blood vessel other substances such as problems foods, preservatives or dyes. Taking other medicines ⋅ kidney problems 2. you are pregnant or intend to Tell your doctor if you are taking ⋅ liver problems become pregnant. any other medicines, including any ⋅ low potassium and/or low Clopixol may affect your that you buy without a prescription magnesium levels in the fertility. If you are intending to from your pharmacy, supermarket blood start a family, ask your doctor or health food shop. for advice. ⋅ organic brain syndrome Some medicines and Clopixol may interfere with each other. These Like most medicines of this ⋅ parkinsonism, a disease of the include: kind, Clopixol is not brain affecting movement recommended for use during ⋅ risk factors for stroke ⋅ tricyclic antidepressants and pregnancy unless clearly ⋅ tardive dyskinesia, a reaction lithium, medicines used to treat necessary. The general to some medicines with depression or mood swings condition of your baby might be worm-like movements of the ⋅ medicines used to treat strong pain affected by the use of this tongue, or other uncontrolled ⋅ medicines used to produce medicine. movements of the mouth, calmness or to help you sleep The following symptoms may tongue, cheeks or jaw which ⋅ medicines used to treat high blood occur in newborn babies of may progress to the arms and pressure (hypertension), such as mothers who have used legs. guanethidine Clopixol in the last three months ⋅ treatment for cancer ⋅ levodopa, a medicine used to treat of their pregnancy: shaking, ⋅ if you or someone else in your Parkinson’s disease muscle stiffness and/or family has a history of blood ⋅ medicines which stimulate the weakness, sleepiness, agitation, clots, as medicines like these body, getting it ready for action, breathing problems and have been associated with such as adrenaline difficulty in feeding. If your formation of blood clots ⋅ metoclopramide, a medicine used baby develops any of these ⋅ sleep apnoea (a sleep disorder to relieve nausea and vomiting symptoms you should contact where your breathing is ⋅ piperazine, a medicine used to treat your doctor. interrupted during sleep). worm infections 3. you are breast-feeding or Also tell your doctor if you will be ⋅ medicines known to inhibit the planning to breast-feed. in a hot environment or you do a activity of certain liver enzymes lot of vigorous exercise. It is not recommended that you ⋅ medicines used to treat changes in Clopixol may make you sweat less, breast-feed while using the rhythm or rate of the heart beat, causing your body to overheat. Clopixol. Its active ingredient e.g. quinidine, amiodarone, sotalol passes into breast milk and Tell your doctor if you are exposed and dofetilide therefore there is a possibility to pesticides that contain ⋅ antipsychotics, a class of medicines that your baby might be phosphorus. used to treat certain mental and affected. The risk of you experiencing a side emotional conditions, e.g. effect may be increased. 4. you have, or have had, the thioridazine following medical conditions: If you are lactose intolerant, ⋅ certain medicines used to treat ⋅ arteriosclerosis, a disease contact your doctor before taking infections, such as erythromycin, affecting the arteries Clopixol tablets. gatifloxacin and moxifloxacin Clopixol tablets contain lactose. ⋅ convulsions, fits or seizures ⋅ medicines used to relieve the ⋅ decreased blood supply to Do not give Clopixol to a child or symptoms of allergy, including the brain adolescent. terfenadine and astemizole ⋅ diabetes, a disorder of There is no experience with its use in ⋅ cisapride, used to treat stomach metabolism in which the children or adolescents under problems 18 years old. amount of sugar in the blood ⋅ medicines that disturb water or salt is too high balance e.g. thiazide diuretics, also ⋅ feeling lethargic, indifferent, called fluid or water tablets lost or remote 2 ⋅ medicines known to increase the Clopixol Depot injection same effects on your illness, although concentration of Clopixol in The usual dose is 200 to 400 mg they last for different lengths of time. your blood (1 to 2 mL) every second to fourth Clopixol tablets ⋅ medicines used to relieve week. Clopixol tablets only work for a short stomach cramps or spasms, to Your doctor will decide what dose time, so they need to be taken every prevent travel sickness and to you will receive. This depends on day. treat Parkinson’s disease, such your condition and other factors, Take Clopixol tablets once a day at as atropine or related medicines. such as your weight and your about the same time. ⋅ medicines used to treat cancer response to the medicine. Generally, Taking them at the same time each day your doctor will start you on smaller will also help you remember when to doses which will be gradually These medicines may be affected by take the tablets. Clopixol, or may affect how well it increased until a dose is reached works. You may need to use where Clopixol works best for you. Take Clopixol tablets before or after food. different amounts of your Your doctor may have prescribed a medicines, or take different different dose. Clopixol injections medicines. Your doctor will advise Clopixol Acuphase injection has to be you. Ask your doctor or pharmacist if given every 2 - 3 days, while Clopixol you are unsure of the correct dose Depot injection lasts several weeks, so Your doctor or pharmacist has more for you. Follow the instructions it is given once every 2 - 4 weeks. information on medicines to be they give you. careful with or avoid while using They will tell you exactly how much Your doctor will advise you. Clopixol. you will be given. Elderly patients How long to use it The dosage of Clopixol may need to Continue taking your tablets and/or be reduced in elderly patients. How to use it having your injections for as long as your doctor tells you to. How to use it Clopixol helps control your condition, How much to use but does not cure it. Therefore, you Clopixol tablets Clopixol tablets will need regular treatment. The usual dose is 10 to 50 mg per Swallow the tablets whole with a full glass of water.
Load more

Recommended publications
  • Ecstasy and the Concomitant Use of Pharmaceuticals
    J.Copeland, P. Dillon & M. Gascoigne Ecstasy and the Concomitant Use of Pharmaceuticals NDARC Technical Report No. 201 ECSTASY AND THE CONCOMITANT USE OF PHARMACEUTICALS Jan Copeland (PhD), Paul Dillon & Michael Gascoigne Technical Report Number 201 ISBN: 1 877027 92 8 ©National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 2004 This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. All other rights are reserved. Requests and enquiries concerning reproduction and rights should be addressed to the information manager, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia. 2 ACKNOWLEDGEMENT This study and report was funded by the Australian Government Department of Health and Ageing’s National Illicit Drug Strategy. It was conducted concurrently with a study of aspects of information seeking among ecstasy users and there is some replication of the data presented on demographic characteristics and perception of ecstasy related harms in this Technical Report and Technical Report Number 202. 3 TABLE OF CONTENTS ACKNOWLEDGEMENT 3 TABLE OF CONTENTS 4 TABLE OF TABLES 5 EXECUTIVE SUMMARY 6 INTRODUCTION 7 Anti-depressant medication 8 5-hydroxytryptophan 9 Attention Deficit Hyperactivity Disorder 11 Sildenafil Citrate 12 Benzodiazepines 13 Study Ains 14 METHOD 15 Participants 15 Procedure 15 Measures 15 RESULTS 17 Demographics
    [Show full text]
  • Clopixol Acuphase®)
    Guidelines for the use of zuclopenthixol acetate injection (Clopixol Acuphase®) Version 3.1 – January 2018 GUIDELINE REPLACED Version 3 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED October 2015 NEXT REVIEW DATE January 2021 EXECUTIVE SPONSOR Executive Medical Director ORIGINAL AUTHOR Jed Hewitt – Chief Pharmacist Review / update – 2015 Helen Manuell – Lead Pharmacist (ESx) Review / update - 2018 Jed Hewitt – Chief Pharmacist If you require this document in an alternative format, i.e. easy read, large text, audio or Braille please contact the pharmacy team on 01243 623349. Guidelines for the use of zuclopenthixol acetate injection (Clopixol Acuphase®) Introduction In the past, Acuphase® has often been too widely and possibly inappropriately used, sometimes without full regard being given to the fact that it is a potentially hazardous and toxic preparation with very little published information to support its use. Indeed, the Cochrane Library concludes that there is inadequate data on Acuphase® and no convincing evidence to support its use in acute psychiatric emergency. So far as possible, it should therefore be reserved for the minority of patients who have a prior history of previous use and good response, with use defined in an advance directive. Similarly, as a general rule Acuphase® should not be used for rapid tranquillisation unless such practice is also in accordance with an advance directive. Normally, Acuphase® should never be considered as a first-line drug for rapid tranquillisation as its onset of action will often not be rapid enough in these circumstances. In addition, the administration of an oil-based injection carries very high risk in a highly agitated patient.
    [Show full text]
  • CENTRAL NERVOUS SYSTEM DEPRESSANTS Opioid Pain Relievers Anxiolytics (Also Belong to Psychiatric Medication Category) • Codeine (In 222® Tablets, Tylenol® No
    CENTRAL NERVOUS SYSTEM DEPRESSANTS Opioid Pain Relievers Anxiolytics (also belong to psychiatric medication category) • codeine (in 222® Tablets, Tylenol® No. 1/2/3/4, Fiorinal® C, Benzodiazepines Codeine Contin, etc.) • heroin • alprazolam (Xanax®) • hydrocodone (Hycodan®, etc.) • chlordiazepoxide (Librium®) • hydromorphone (Dilaudid®) • clonazepam (Rivotril®) • methadone • diazepam (Valium®) • morphine (MS Contin®, M-Eslon®, Kadian®, Statex®, etc.) • flurazepam (Dalmane®) • oxycodone (in Oxycocet®, Percocet®, Percodan®, OxyContin®, etc.) • lorazepam (Ativan®) • pentazocine (Talwin®) • nitrazepam (Mogadon®) • oxazepam ( Serax®) Alcohol • temazepam (Restoril®) Inhalants Barbiturates • gases (e.g. nitrous oxide, “laughing gas”, chloroform, halothane, • butalbital (in Fiorinal®) ether) • secobarbital (Seconal®) • volatile solvents (benzene, toluene, xylene, acetone, naptha and hexane) Buspirone (Buspar®) • nitrites (amyl nitrite, butyl nitrite and cyclohexyl nitrite – also known as “poppers”) Non-Benzodiazepine Hypnotics (also belong to psychiatric medication category) • chloral hydrate • zopiclone (Imovane®) Other • GHB (gamma-hydroxybutyrate) • Rohypnol (flunitrazepam) CENTRAL NERVOUS SYSTEM STIMULANTS Amphetamines Caffeine • dextroamphetamine (Dexadrine®) Methelynedioxyamphetamine (MDA) • methamphetamine (“Crystal meth”) (also has hallucinogenic actions) • methylphenidate (Biphentin®, Concerta®, Ritalin®) • mixed amphetamine salts (Adderall XR®) 3,4-Methelynedioxymethamphetamine (MDMA, Ecstasy) (also has hallucinogenic actions) Cocaine/Crack
    [Show full text]
  • Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
    pharmaceutics Review Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics Francisco José Toja-Camba 1,2,† , Nerea Gesto-Antelo 3,†, Olalla Maroñas 3,†, Eduardo Echarri Arrieta 4, Irene Zarra-Ferro 2,4, Miguel González-Barcia 2,4 , Enrique Bandín-Vilar 2,4 , Victor Mangas Sanjuan 2,5,6 , Fernando Facal 7,8 , Manuel Arrojo Romero 7, Angel Carracedo 3,9,10,* , Cristina Mondelo-García 2,4,* and Anxo Fernández-Ferreiro 2,4,* 1 Pharmacy Department, University Clinical Hospital of Ourense (SERGAS), Ramón Puga 52, 32005 Ourense, Spain; [email protected] 2 Clinical Pharmacology Group, Institute of Health Research (IDIS), Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain; [email protected] (I.Z.-F.); [email protected] (M.G.-B.); [email protected] (E.B.-V.); [email protected] (V.M.S.) 3 Genomic Medicine Group, CIMUS, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain; [email protected] (N.G.-A.); [email protected] (O.M.) 4 Pharmacy Department, University Clinical Hospital of Santiago de Compostela (SERGAS), Citation: Toja-Camba, F.J.; 15706 Santiago de Compostela, Spain; [email protected] Gesto-Antelo, N.; Maroñas, O.; 5 Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Echarri Arrieta, E.; Zarra-Ferro, I.; 46100 Valencia, Spain González-Barcia, M.; Bandín-Vilar, E.; 6 Interuniversity Research Institute for Molecular Recognition and Technological Development,
    [Show full text]
  • Antipsychotic Codes Used from Drug Programs Information Network (DPIN) Database
    Antipsychotic Codes Used from Drug Programs Information Network (DPIN) Database Drug Identification Anatomical Therapeutic Chemical Equivalent Generic Product Name Product Description Number (DIN) (ATC) Drug Classification HALOPERIDOL INJECTION 17574 HALDOL INJECTION 5MG/ML N05AD01 HALOPERIDOL TRIFLUOPERAZINE HCL 21865 NOVO-FLURAZINE TAB 2MG N05AB06 TRIFLUOPERAZINE TRIFLUOPERAZINE HCL 21873 NOVO-FLURAZINE TAB 5MG N05AB06 TRIFLUOPERAZINE TRIFLUOPERAZINE HCL 21881 NOVO-FLURAZINE TAB 10MG N05AB06 TRIFLUOPERAZINE THIORIDAZINE 27375 MELLARIL SUS 10MG/5ML N05AC02 THIORIDAZINE FLUPHENAZINE ENANTHATE 29173 MODITEN ENANTHATE INJ 25MG/ML N05AB02 FLUPHENAZINE THIORIDAZINE HYDROCHLORIDE 37486 NOVO-RIDAZINE 50MG N05AC02 THIORIDAZINE THIORIDAZINE HYDROCHLORIDE 37494 NOVO-RIDAZINE 25MG N05AC02 THIORIDAZINE THIORIDAZINE HYDROCHLORIDE 37508 NOVO-RIDAZINE 10MG N05AC02 THIORIDAZINE CHLORPROMAZINE HCL 232157 NOVO-CHLORPROMAZINE TAB 10MG N05AA01 CHLORPROMAZINE CHLORPROMAZINE HCL 232807 NOVO-CHLORPROMAZINE TAB 50MG N05AA01 CHLORPROMAZINE CHLORPROMAZINE HCL 232823 NOVO-CHLORPROMAZINE TAB 25MG N05AA01 CHLORPROMAZINE CHLORPROMAZINE HCL 232831 NOVO-CHLORPROMAZINE TAB 100MG N05AA01 CHLORPROMAZINE LITHIUM CARBONATE 236683 CARBOLITH CAP 300MG N05AN01 LITHIUM TRIFLUOPERAZINE HCL 312746 APO TRIFLUOPERAZINE TAB 5MG N05AB06 TRIFLUOPERAZINE TRIFLUOPERAZINE HCL 312754 APO TRIFLUOPERAZINE TAB 2MG N05AB06 TRIFLUOPERAZINE PIMOZIDE 313815 ORAP TAB 2MG N05AG02 PIMOZIDE PIMOZIDE 313823 ORAP TAB 4MG N05AG02 PIMOZIDE TRIFLUOPERAZINE HCL 326836 APO TRIFLUOPERAZINE TAB 10MG N05AB06
    [Show full text]
  • Guidance on the Treatment of Antipsychotic Induced Hyperprolactinaemia in Adults
    Guidance on the Treatment of Antipsychotic Induced Hyperprolactinaemia in Adults Version 1 GUIDELINE NO RATIFYING COMMITTEE DRUGS AND THERAPEUTICS GROUP DATE RATIFIED April 2014 DATE AVAILABLE ON INTRANET NEXT REVIEW DATE April 2016 POLICY AUTHORS Nana Tomova, Clinical Pharmacist Dr Richard Whale, Consultant Psychiatrist In association with: Dr Gordon Caldwell, Consultant Physician, WSHT . If you require this document in an alternative format, ie easy read, large text, audio, Braille or a community language, please contact the Pharmacy Team on 01243 623349 (Text Relay calls welcome). Contents Section Title Page Number 1. Introduction 2 2. Causes of Hyperprolactinaemia 2 3. Antipsychotics Associated with 3 Hyperprolactinaemia 4. Effects of Hyperprolactinaemia 4 5. Long-term Complications of Hyperprolactinaemia 4 5.1 Sexual Development in Adolescents 4 5.2 Osteoporosis 4 5.3 Breast Cancer 5 6. Monitoring & Baseline Prolactin Levels 5 7. Management of Hyperprolactinaemia 6 8. Pharmacological Treatment of 7 Hyperprolactinaemia 8.1 Aripiprazole 7 8.2 Dopamine Agonists 8 8.3 Oestrogen and Testosterone 9 8.4 Herbal Remedies 9 9. References 10 1 1.0 Introduction Prolactin is a hormone which is secreted from the lactotroph cells in the anterior pituitary gland under the influence of dopamine, which exerts an inhibitory effect on prolactin secretion1. A reduction in dopaminergic input to the lactotroph cells results in a rapid increase in prolactin secretion. Such a reduction in dopamine can occur through the administration of antipsychotics which act on dopamine receptors (specifically D2) in the tuberoinfundibular pathway of the brain2. The administration of antipsychotic medication is responsible for the high prevalence of hyperprolactinaemia in people with severe mental illness1.
    [Show full text]
  • Product Monograph
    PRODUCT MONOGRAPH PrCLOPIXOL® Zuclopenthixol Tablets Lundbeck Std. (10 mg and 25 mg zuclopenthixol as zuclopenthixol hydrochloride) Lundbeck standard PrCLOPIXOL-ACUPHASE® 50 mg/mL Zuclopenthixol Intramuscular Injection (45.25 mg/mL zuclopenthixol as zuclopenthixol acetate) Lundbeck standard PrCLOPIXOL® DEPOT 200 mg/mL Zuclopenthixol Intramuscular Injection (144.4 mg/mL zuclopenthixol as zuclopenthixol decanoate) Lundbeck standard Antipsychotic Agent Lundbeck Canada Inc. Date of Revision: 2600 Alfred-Nobel October 16th, 2020 Suite 400 St-Laurent, QC H4S 0A9 Submission Control No : 171198 Page 1 of 34 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION .........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................3 CONTRAINDICATIONS ...................................................................................................4 WARNINGS AND PRECAUTIONS ..................................................................................4 ADVERSE REACTIONS ....................................................................................................9 DRUG INTERACTIONS ..................................................................................................13 DOSAGE AND ADMINISTRATION ..............................................................................14 OVERDOSAGE ................................................................................................................18
    [Show full text]
  • Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period
    Supplementary Online Content Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naïve patients in the postoperative period. JAMA Intern Med. Published online July 11, 2016. doi:10.1001/jamainternmed.2016.3298. eTable 1. List of CPT Codes eFigure. Sample Construction Flow Chart eTable 2. List of Drug Classes eTable 3. List of Medical Comorbidities and ICD-9 Codes eTable 4. Sample Summary Characteristics, by procedure eTable 5. Risk Factors for Chronic Opioid Use Following Surgery Among Opioid Naïve Patients This supplementary material has been provided by the authors to give readers additional information about their work. © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/29/2021 eTable 1. List of CPT codes CPT Codes Total Knee Arthroplasty1 27447 Total Hip Arthroplasty1 27130 Laparoscopic Cholecystectomy2 47562, 47563, 47564 Open Cholecystectomy3 47600, 47605, 47610 Laparoscopic Appendectomy4 44970, 44979 Open Appendectomy5 44950, 44960 Cesarean Section6 59510, 59514, 59515 FESS7 31237, 31240, 31254, 31255, 31256, 31267, 31276, 31287, 31288 Cataract Surgery8 66982, 66983, 66984 TURP9 52601, 52612, 52614 Simple Mastectomy10‐12 19301, 19302, 19303, 19180 © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/29/2021 eFigure. Sample Construction Flow Chart © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/29/2021 eTable 2.
    [Show full text]
  • Psychiatric Medication Information / Arabic 1
    AARRAABBIICC Professor David Castle Ms. Nga Tran St. Vincent’s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065 (03) 9288 4147 (03) 9288 4751 Psychiatric Medication Information / Arabic 1 Psychiatric Medication Information / Arabic 2 dosette box blister pack Psychiatric Medication Information / Arabic 3 PRN ANTIPSYCHOTICS ANTIDEPRESSANTS SSRIs (Selective Serotonin Reuptake Inhibitors) SNRIs (Serotonin Noradrenaline Reuptake Inhibitors Psychiatric Medication Information / Arabic 4 Noradrenaline and Specific Serotonin Antagonists (NaSSAs) Noraderenaline Reuptake Inhibitors (NaRIs) NaSSAs NaRIs Tricyclic Antidepressants (TCAs) MOOD STABILISERS Lithium Carbamazepine Sodium Valproate Anxiolytics Benzodiazepines benzhexol benztropine Anticholinergic drugs biperiden Beta Blockers Psychiatric Medication Information / Arabic 5 ® Chlorpromazine (Largactil ), Thioridazine (Aldazine®), Trifluoperazine (Stelazine®), Haloperidol ® ® ® (Serenace , Haldol ), Flupenthixol (Fluanxol ), Zuclopenthixol (Clopixol®) ® ® Risperidone (Risperdal ), Olanzapine (Zyprexa ), Quetiapine (Seroquel®), Clozapine Clozapine ® ® ® (Clopine /Clozaril ), Amisulpride (Solian ), Aripiprazole (Abilify®), Ziprasidone (Zeldox®), Paliperidone (Invega®) ® ® Imipramine (Tofranil ), Amitriptyline (Tryptanol ), Dothiepin (Prothiaden®), Doxepin (Sinequan®), ® ® Nortriptyline (Allegron ), Trimipramine (Surmontil ) (SSRIs) ® ® Fluoxetine (Prozac ), Sertraline (Zoloft ), Citalopram (Cipramil®), Paroxetine (Aropax®), Fluvoxamine ® ® (Luvox ), Escitalopram (Lexapro ) (SNRI)
    [Show full text]
  • Long-Acting Injectable Antipsychotics. Review and Recent Developments
    Review Article Monica Zolezzi, BPharm, MSc. ABSTRACT Long-acting injectable antipsychotics, also known as "depots", were developed in the late 1960s as an attempt to improve compliance and long-term management of schizophrenia. Despite their availability for over 30 years, guidelines for their use and data on patients for whom long-acting injectable antipsychotics are most indicated are sparse and vary considerably. A review of the perceived advantages and disadvantages of using long-acting injectable antipsychotics is provided in this article, as well as a review of the literature to update clinicians on the current advances of this therapeutic option to optimize compliance and long-term management of chronic schizophrenia. Neurosciences 2005; Vol. 10 (2): 126-131 chizophrenia is a chronic disorder for which it is hydrolyze the esterified compound and liberates the Swell recognized that lifelong treatment with parent antipsychotic.2,9,10 Although depot antipsychotics is necessary. Although quite antipsychotics have been available for over 30 successful in treating and preventing relapses,1,2 years, guidelines for their use and data on patients antipsychotics are not readily accepted by patients, for whom long-acting injectables are most indicated thus, non-compliance is common.3,4 Thus, are sparse and vary considerably. In addition, long-acting injectable forms of these medications despite the fact that the use of depot antipsychotics were developed in an attempt to help medication has been extensively promoted to overcome patient compliance
    [Show full text]
  • Should Inverse Agonists Be Defined by Pharmacological Mechanism Or
    CNS Spectrums,(2019), 24 354 – 370. © Cambridge University Press 2018. This is an Open Access article, distributed under the terms , of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. doi:10.1017/S1092852918001098 REVIEW ARTICLE Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics Christoph U. Correll ,1,2 Jennifer Kern Sliwa ,3* Dean M. Najarian ,3 and Stephen R. Saklad4 1 Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York 2 Division of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York 3 Janssen Scientific Affairs LLC, Titusville, New Jersey 4 College of Pharmacy, Pharmacotherapy Division, University of Texas at Austin, San Antonio, Texas With more long-acting injectable (LAI) antipsychotics available for treating schizophrenia, each with variable durations of action (2 weeks to 3 months), it is important to have clear management strategies for patients developing breakthrough psychotic symptoms or experiencing symptomatic worsening on LAIs. However, no treatment guidelines or clinical practice pathways exist; health-care providers must rely on their own clinical judgment to manage these patients. This article provides practical recommendations—based on a framework of clinical, pharmacokinetic, and dosing considerations—to guide clinicians’ decisions regarding management of breakthrough psychotic symptoms.
    [Show full text]
  • Drug-Induced Parkinsonism
    InformationInformation Sheet Sheet Drug-induced Parkinsonism Terms highlighted in bold italic are defined in increases with age, hypertension, diabetes, the glossary at the end of this information sheet. atrial fibrillation, smoking and high cholesterol), because of an increased risk of stroke and What is drug-induced parkinsonism? other cerebrovascular problems. It is unclear About 7% of people with parkinsonism whether there is an increased risk of stroke with have developed their symptoms following quetiapine and clozapine. See the Parkinson’s treatment with particular medications. This UK information sheet Hallucinations and form of parkinsonism is called ‘drug-induced Parkinson’s. parkinsonism’. While these drugs are used primarily as People with idiopathic Parkinson’s disease antipsychotic agents, it is important to note and other causes of parkinsonism may also that they can be used for other non-psychiatric develop worsening symptoms if treated with uses, such as control of nausea and vomiting. such medication inadvertently. For people with Parkinson’s, other anti-sickness drugs such as domperidone (Motilium) or What drugs cause drug-induced ondansetron (Zofran) would be preferable. parkinsonism? Any drug that blocks the action of dopamine As well as neuroleptics, some other drugs (referred to as a dopamine antagonist) is likely can cause drug-induced parkinsonism. to cause parkinsonism. Drugs used to treat These include some older drugs used to treat schizophrenia and other psychotic disorders high blood pressure such as methyldopa such as behaviour disturbances in people (Aldomet); medications for dizziness and with dementia (known as neuroleptic drugs) nausea such as prochlorperazine (Stemetil); are possibly the major cause of drug-induced and metoclopromide (Maxolon), which is parkinsonism worldwide.
    [Show full text]